Advanced search
Publication Cover
Journal of Medical Economics Volume 19, 2016 - Issue 1
Submit an article Journal homepage
588
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting β2-agonists

Yaozhu J. Chen1 Onyx Pharmaceuticals, Inc., South San Francisco, CA, USA
,
Charles Makin2 HEOR & Strategic Market Access, Mapi Group, Boston, MA, USA
,
Vamsi K. Bollu3 HEOR, Sunovion Pharmaceuticals, Inc., Marlborough, MA, USA
,
Maryam Navaie4 Advance Health Solutions, LLC, San Diego, CA, USACorrespondence[email protected]
&
Bartolome R. Celli5 Harvard Medical School, Boston, MA, USA, and Chronic Obstructive Pulmonary Disease Center, Brigham and Women’s Hospital, Boston, MA, USA
Pages 11-20 | Accepted 31 Jul 2015, Published online: 20 Aug 2015

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Todd P Gilmer. (2019) Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1019-1031.
Read now
Todd P. Gilmer, Bartolome R. Celli, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Maryam Navaie. (2019) Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease*. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 140-151.
Read now
Vaidyanathan Ganapathy & Michael D Stensland. (2017) Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1793-1801.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.